SCHEMBL7969626

SCHEMBL7969626

Cc1cc(Br)cc(C)c1Nc1nc2ccccc2n2cncc12

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983700 0.92 LCK (0.84) LCK
SCHEMBL7969485 0.90 LCK (1.00) LCK
SCHEMBL7981613 0.88 LCK (0.81) LCK
SCHEMBL7980767 0.87 LCK (1.00) LCK
SCHEMBL7970810 0.86 LCK (0.69) LCK
SCHEMBL7980244 0.85 LCK (0.78) LCK
SCHEMBL7987291 0.85 LCK (1.00) LCK
SCHEMBL4036055 0.84 LCK (0.58) LCK
SCHEMBL7970102 0.84 LCK (0.73) LCK
SCHEMBL7984724 0.82 LCK (1.00) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed